Ocata Therapeutics Inc fka OCAT

[homeslice10]

I think your post is a foul ball. Its pretty clear in the amended 10K that shareholder rights are fully addressed and in the standard operating procedure, dating back to 2013. I think current management is doing that to inform shareholders that they are not going to be exploited in any way that would be abnormal, and for you to insinuate that bankruptcy is an option when its not even remotely reasonable is just a disguised attempt to create fear, in my opinion. The shareholders' concerns are in fact addressed and Myles is doing a great job providing that in company writing (10K).

As for the JV and uplist, what big pharma wouldn't want this in their pipeline?